Cardiovascular Catheters Market by Catheters, Usability, End-User

Description

List of Tables

[198 Pages Report] The Cardiovascular Catheters Market size was estimated at USD 12.79 billion in 2023 and expected to reach USD 13.71 billion in 2024, at a CAGR 7.41% to reach USD 21.10 billion by 2030.

Cardiovascular catheters are specialized medical devices designed for navigating through blood vessels to deliver therapies or perform diagnostic procedures relating to the heart and other parts of the cardiovascular system. They are slender, tube-like instruments that are guided into place through the circulatory system under imaging guidance. With increasing numbers of individuals affected by cardiovascular conditions worldwide, there is a growing need for effective diagnostic and therapeutic solutions such as cardiovascular catheters. Government initiatives to raise awareness for heart health and heart conditions, coupled with the expansion of clinics, hospitals, and surgical and diagnostics centers, have accentuated the adoption of critical medical devices such as cardiovascular catheters. However, the technical complexity of catheterization requires highly skilled professionals, which can restrict the availability of these procedures in regions with shortages of specialized healthcare providers. Performance and safety issues such as risks of infection and contamination and malfunctioning of the device can raise concerns about the reliability of cardiovascular catheters. Innovations in catheter technology, including the development of more flexible and durable materials, as well as enhancements in the precision of catheter-based interventions, can expand the scope and effectiveness of treatments available for heart diseases.

KEY MARKET STATISTICS
Base Year [2023]	USD 12.79 billion
Estimated Year [2024]	USD 13.71 billion
Forecast Year [2030]	USD 21.10 billion
CAGR (%)	7.41%

Regional Insights

In the Americas, particularly the United States and Canada, there is a high prevalence of cardiovascular diseases owing to dietary and lifestyle changes and an aging population. Healthcare providers in the Americas region are increasingly adopting advanced technologies for managing cardiovascular conditions, driving the need for sophisticated cardiovascular catheters for diagnosis and treatment. Investment in research and development is robust, supported by both private and public funding. Recent patents in the region have focused on innovations in catheter durability and the precision of diagnostic features. EU countries benefit from well-established healthcare systems and uniform regulatory standards, which enhance the accessibility and adoption of new medical technologies, including cardiovascular catheters. There is a heightened focus on improving the biocompatibility of cardiovascular catheters, giving rise to robust R&D initiatives. In the APAC region, China and Japan present a need for cardiovascular catheters due to large aging populations and the increasing prevalence of lifestyle diseases. APAC nations are rapidly expanding their healthcare infrastructure, supported by governmental initiatives aimed at incorporating more advanced medical technologies. The expansion of healthcare facilities in rural and remote locations and a heightened emphasis on advancing local manufacturing of medical devices provide a conducive framework for the growth of cardiovascular catheters in the APAC region.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Cardiovascular Catheters Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
- Rising prevalence of cardiovascular disease across the globe
- Surging advancements in the imaging technologies
- Government initiatives for the cardiovascular diseases management

Market Restraints
- Associated complications and issues with cardiac catheterization

Market Opportunities
- Introduction of advanced cardiac catheters
- Promising reimbursement policies for coronary intervention procedures

Market Challenges
- Stringent regulatory norms for the product approvals

Market Segmentation Analysis
- Catheters: Expanding utilization of percutaneous transluminal coronary angioplasty balloon catheters (PTCA) to cater to the growing global incidence of coronary artery diseases
- End-User: Upgradation and expansion of hospital facilities across the world

Market Disruption Analysis
Porter's Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cardiovascular Catheters Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cardiovascular Catheters Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Cook Medical Partners with Bentley to Distribute BeBack Crossing Catheter in the USA

Cook Medical has entered into a distribution agreement with Bentley to market the BeBack crossing catheter in the United States, enhancing Cook's peripheral intervention portfolio. This collaboration enables greater access to the BeBack device, which is essential for navigating chronic total occlusions (CTO) and facilitating precise re-entry, particularly in heavily calcified lesions. [Published On: 2024-03-21]

Introduction of the Micro Rx Microcatheter by Biotronik, Enhancing Guidewire Support in Percutaneous Coronary Interventions

Biotronik has introduced the Micro Rx microcatheter in the USA, a cutting-edge device designed to improve guidewire support during percutaneous coronary interventions (PCI). This rapid exchange microcatheter, the fourth product from Interventional Medical Device Solutions (IMDS) distributed by Biotronik in the U.S. market, features a robust design with a reinforced distal shaft and a core wire sandwiched between two braiding layers to ensure efficient push transfer. I [Published On: 2024-02-08]

Introduction of Enhanced Shockwave C2+ Catheter Promises Improved Cardiovascular Treatment

Shockwave Medical is set to introduce its advanced Shockwave C2+ coronary intravascular lithotripsy (IVL) catheter at the Transcatheter Cardiovascular Therapeutics (TCT) symposium. The C2+ catheter aims to improve procedural efficiency and is already marketed for treating de novo coronary artery disease in the U.S., Europe, and other regions. The company highlighted the device's enhanced capacity to treat complex calcium cases in cardiovascular procedures including diffuse disease and eccentric calcifications. [Published On: 2023-10-20]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cardiovascular Catheters Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Cardiovascular Catheters Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics Inc., Asahi Intecc Co., Ltd., B. Braun SE, Becton, Dickinson and Company, Boston Scientific Corp., Cardinal Health, Coloplast Corp., Cook Group Incorporated, Cordis Corporation, Edwards Lifesciences, Getinge AB, Infraredx by Nipro Corp., Integer Holdings Corp., Johnson & Johnson Services, Inc., McKesson Medical-Surgical Inc., Medtronic PLC, Merit Medical Systems, Microport Scientific Corp., Penumbra, Inc., Smith+Nephew PLC, Stryker Corporation, Teleflex Inc., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiovascular Catheters Market to forecast the revenues and analyze trends in each of the following sub-markets:

Catheters
- Electrophysiology Catheters
- Guide Extension Catheter
- Intravascular Ultrasound Catheters
- Percutaneous Transluminal Angioplasty Balloons Catheters
- Percutaneous Transluminal Coronary Angioplasty Balloons Catheters

Usability
- Disposable
- Reusable

End-User
- Ambulatory Surgical Centers
- Clinics
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

Product Code: MRR-DD0700E81DCB

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising prevalence of cardiovascular disease across the globe
  - 5.1.1.2. Surging advancements in the imaging technologies
  - 5.1.1.3. Government initiatives for the cardiovascular diseases management
- 5.1.2. Restraints
  - 5.1.2.1. Associated complications and issues with cardiac catheterization
- 5.1.3. Opportunities
  - 5.1.3.1. Introduction of advanced cardiac catheters
  - 5.1.3.2. Promising reimbursement policies for coronary intervention procedures
- 5.1.4. Challenges
  - 5.1.4.1. Stringent regulatory norms for the product approvals
5.2. Market Segmentation Analysis
- 5.2.1. Catheters: Expanding utilization of percutaneous transluminal coronary angioplasty balloon catheters (PTCA) to cater to the growing global incidence of coronary artery diseases
- 5.2.2. End-User: Upgradation and expansion of hospital facilities across the world
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Cardiovascular Catheters Market, by Catheters

6.1. Introduction
6.2. Electrophysiology Catheters
6.3. Guide Extension Catheter
6.4. Intravascular Ultrasound Catheters
6.5. Percutaneous Transluminal Angioplasty Balloons Catheters
6.6. Percutaneous Transluminal Coronary Angioplasty Balloons Catheters

7. Cardiovascular Catheters Market, by Usability

7.1. Introduction
7.2. Disposable
7.3. Reusable

8. Cardiovascular Catheters Market, by End-User

8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Clinics
8.4. Hospitals

9. Americas Cardiovascular Catheters Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Cardiovascular Catheters Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Cardiovascular Catheters Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
- 12.3.1. Cook Medical Partners with Bentley to Distribute BeBack Crossing Catheter in the USA
- 12.3.2. Introduction of the Micro Rx Microcatheter by Biotronik, Enhancing Guidewire Support in Percutaneous Coronary Interventions
- 12.3.3. Introduction of Enhanced Shockwave C2+ Catheter Promises Improved Cardiovascular Treatment
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio